Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an announcement.
Wai Chun Bio-Technology Ltd. announced that its subsidiary, Century-Light, entered into a Loan Agreement with a borrower, resulting in multiple unsecured, interest-bearing drawdowns. These drawdowns, which were fully settled by May 2025, led to major and disclosable transactions under Hong Kong’s Listing Rules due to their significant percentage ratios. The company breached certain listing rules by not announcing the drawdowns timely, but received written approval from a major shareholder, negating the need for a general meeting. A circular detailing the drawdowns will be dispatched to shareholders by January 2026.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. operates in the biotechnology industry, focusing on providing innovative solutions and services. The company is involved in various financial transactions and investments, aiming to strengthen its market position and expand its operational capabilities.
Average Trading Volume: 138,611
Technical Sentiment Signal: Buy
Current Market Cap: HK$34.45M
See more insights into 0660 stock on TipRanks’ Stock Analysis page.